U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
The Ministry of Health has issued manuals on genetics, standards of identification, treatment and prevention of Zika virus.
Passengers flying from Yerevan and onwards will enjoy a quick and convenient transfer at Hamad International Airport.
Six members of the Avetisian family, including a 2-year-old girl, were found dead on January 12, 2015, in their home in Gyumri, Armenia.
“94 out of 124 pregnant women, 982 out of 1230 patients with acute respiratory viruses are under supervision,” the Minister stated.
Partner news